Health · 2 views
New human data hints at psychedelics' potential to combat inflammation
Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses.
Summary
Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Not enjoying being a parent? You're not alone. Here's how to handle this complicated feelingContinue reading
- Functional MRI looks beyond the brain to reveal spinal cord activityContinue reading
- Another Incretin Drug Proves Mettle in Sleep ApneaContinue reading
- Hep B Vax Doses Seized; RFK Jr.'s Brazil Photos; MAHA Advisor's COI WaiverContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow